XML 24 R9.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net income/(loss) $ 192,459 $ (18,281) $ 141,722
Adjustments to reconcile net income/(loss) to net cash provided by operating activities      
Stock-based compensation 22,278 22,639 23,170
Depreciation and amortization 15,208 17,360 21,337
Loss on disposal of fixed assets 526 561 920
Impairment of intangibles 2,620 44,273 4,050
Impairment of lease right-of-use asset and fixed assets 1,432 36,895 1,883
Deferred taxes 1,280 (8,353) 5,144
Increase (Decrease) in Accrued Interest Receivable, Net 23 31 40
Note receivable - related party 409 409 409
Loss (gain) on sale of marketable securities 0 0 5
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 11,862 (8,917) 0
Gain on sale of trademark (8,000) 0 0
Net benefit in connection with reversal of contingent liability partially offset by acceleration of amortization related to Kate Spade license termination 0 0 (1,868)
Provision for Doubtful Accounts (919) 0 8,687
Changes in:      
Accounts receivable (583) 13,122 (17,837)
Due from factor (112,311) (36,200) 24,924
Inventories (153,793) 35,476 8,436
Prepaid expenses, prepaid taxes, deposits and other (1,899) (10,129) 9,466
Accounts payable and accrued expenses 185,741 (34,207) 11,036
Accrued incentive compensation 10,998 (7,061) (249)
Leases and other liabilities (7,822) (3,350) (7,415)
Net cash provided by operating activities 159,463 44,206 233,780
Cash flows from investing activities:      
Capital expenditures (6,608) (6,562) (18,311)
Purchases of short-term investments (68,471) (73,792) (67,935)
Maturity/sale of marketable securities and short-term investments 63,867 75,470 95,671
Proceeds from sale of a trademark 8,000 0 0
Acquisitions, net of cash acquired 0 0 37,173
Net cash used in investing activities (3,212) (4,884) (27,748)
Cash flows from financing activities:      
Proceeds from exercise of stock options 9,732 1,609 6,212
Investment of noncontrolling interest 0 359 3,248
Payments to Acquire Interest in Joint Venture (18,942) 0 0
Distributions to noncontrolling interest earnings 3,121 0 1,444
Common stock purchased for treasury (123,161) (46,583) (101,768)
Cash dividends paid on common stock (49,161) (12,459) (48,426)
Proceeds from Lines of Credit 0 176,784 0
Repayments of Lines of Credit 0 (176,784) 0
Net Cash Provided by (Used in) Financing Activities, Total (184,653) (57,074) (142,178)
Effect of exchange rate changes on cash and cash equivalents 37 1,515 216
Net decrease in cash, cash equivalents (28,365) (16,237) 64,070
Cash and cash equivalents – beginning of year 247,864 264,101 200,031
Cash and cash equivalents – end of year 219,499 247,864 264,101
Cash paid during the year for:      
Interest 0 354 25
Income taxes $ 46,808 $ 5,147 $ 29,552